Rui Qian

1.0k citations
52 papers · 569 indexed · h-index 13
Topics
Nanoparticle-Based Drug Delivery (9 papers)RNA Interference and Gene Delivery (4 papers)Graphene and Nanomaterials Applications (4 papers)
Partner nations
ChinaGermanyHong Kong

In The Last Decade

Rui Qian

44 papers receiving 563 citations

Peers

Rui Qian
Comparison fields: 5 of 126
  • Biomedical Engineering 124
  • Molecular Biology 116
  • Biomaterials 94
  • Materials Chemistry 85
  • Computational Mechanics 68
Replace Jie Cao with:
Jie Cao China
Ziyang Zhang China
Ruofei Wang China
Xiang Wang China
Cheng-Yi Huang Taiwan
Mengxue Liu China
Ankang Hu China
Mingjuan Li China
Rui Qian relative to Jie Cao China Jie Cao's profile →
Citations per field
00.5×3.1×
Jie Cao · 1×
Citations per year

Countries citing papers authored by Rui Qian

Since Specialization
Citations

This map shows the geographic impact of Rui Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Qian more than expected).

Fields of papers citing papers by Rui Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Qian. The network helps show where Rui Qian may publish in the future.

Co-authorship network of co-authors of Rui Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Qian. A scholar is included among the top collaborators of Rui Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Qian. Rui Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 0
5 0
6 0
7 2
8 1
9 4
10 5
11 13
12 6
13 11
14 5
15 12
16 11
17 9
18
T1/T2-weighted magnetic resonance imaging and SPECT imaging guided combined radioisotope therapy and chemotherapy using functionalized reduced graphene oxide-manganese ferrite nanocomposites
1
19 12
20 1

About Rui Qian

Rui Qian is a scholar working on Biomaterials, Safety, Risk, Reliability and Quality and Pharmaceutical Science, having authored 52 papers that have together received 569 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (4 papers) and Graphene and Nanomaterials Applications (4 papers). The work is most often cited by research in Biomaterials (94 citations), Biological Psychiatry (13 citations) and Molecular Medicine (25 citations). Rui Qian has collaborated with scholars based in China, Germany and Hong Kong. Frequent co-authors include Xin Bian, Sergey Litvinov, Marco Ellero, Nikolaus A. Adams, Ziwei Liu, Yong Kong, Hailin Zhou, Kai Yang, Saisai Xiong and Wenrong Cai. Their work appears in journals such as Nature Communications, ACS Nano and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026